Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion [NA]
This clinical trial update reports on a completed study evaluating a wearable patch's ability to detect medication ingestion in people with …
-
CLINICAL_TRIALS withdrawal · 2024-07-30Clinical Trial Update: tDCS and Executive Function Training for Schizophrenia [NA]
A clinical trial evaluating transcranial direct current stimulation (tDCS) with executive function training for schizophrenia has been withd…
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: Reduction of Auditory-Verbal Hallucinations in Schizophrenia Through Cortical Neuromodulation [NA]
A clinical trial update shows recruitment for cortical neuromodulation to reduce auditory-verbal hallucinations in schizophrenia. The study …
-
FDA approval · 2024-07-26FDA Approved: ERZOFRI EXTENDED-RELEASE — Original Application (Shandong Luye Pharmaceutical Co., Ltd.)
The FDA approved a new extended-release product, ERZOFRI EXTENDED-RELEASE, containing paliperidone palmitate under an original NDA from Shan…
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: A Study of MK-8189 in Participants With Schizophrenia (MK-8189-014) [Phase 1]
A Phase 1 study of MK-8189 in participants with schizophrenia has completed, and results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-25Clinical Trial Update: Combining mHealth and Nurse-delivered Care to Improve the Outcomes of People With Serious Mental Illness in West Africa [NA]
This clinical trial update describes a study combining mobile health tools with nurse-delivered care to improve outcomes for people with ser…
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Feasibility Trial of a Lifestyle Intervention for CHR-P [NA]
This clinical trial update notes the completion of a feasibility trial evaluating a lifestyle intervention for people at clinical high risk …
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: A Biological Signature for the Early Differential Diagnosis of Psychosis
This clinical trial update describes a study to identify a biological signature for early differential diagnosis of psychosis, including sch…
-
FDA approval · 2024-07-23FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for fluphenazine hydrochloride as a generic drug.
-
EMA approval · 2024-07-22EMA Authorised: Byannli (previously Paliperidone Janssen-Cilag International) (paliperidone palmitate) — Janssen-Cilag International N.V.
The EU authorised Byannli (paliperidone palmitate) for schizophrenia, as a long-acting injectable antipsychotic under Janssen-Cilag Internat…
-
EMA approval · 2024-07-22EMA Authorised: Trevicta (previously Paliperidone Janssen) (paliperidone palmitate) — Janssen-Cilag International NV
The European Medicines Agency authorised Trevicta, a brand-name long-acting paliperidone palmitate injection for schizophrenia, with Janssen…
-
EMA approval · 2024-07-22EMA Authorised: Xeplion (paliperidone palmitate) — Janssen-Cilag International N.V.
EMA authorised Xeplion (paliperidone palmitate) for schizophrenia, expanding options for long-acting injectable antipsychotics. Janssen-Cila…
-
CLINICAL_TRIALS research · 2024-07-19Clinical Trial Update: VR-based Avatar Therapy for Treatment of Auditory Hallucinations [NA]
A clinical trial at Semmelweis University is evaluating virtual reality avatar therapy for treating auditory hallucinations in schizophrenia…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Kombucha Tea for Improving Defecation in Patients With Schizophrenia- a Randomized Controlled Study [NA]
Completed randomized controlled trial evaluating the effect of kombucha tea on defecation in patients with schizophrenia who have constipati…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Motivational Interviewing for Patients With Acute Psychosis [NA]
The clinical trial evaluating motivational interviewing for patients with acute psychosis, including schizophrenia, has completed. Sponsor: …
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Maintenance Electroconvulsive Therapy (ECT) Versus Aripiprazole in Clozapine-resistant Schizophrenia [Phase 4]
This ClinicalTrials.gov entry describes a Phase 4 trial comparing maintenance electroconvulsive therapy (ECT) to aripiprazole in people with…
-
FDA approval · 2024-07-14FDA Approved: RISPERIDONE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for risperidone from Zydus Lifesciences Limited. This action authorizes a supplemental approval …
-
EMA approval · 2024-07-12EMA Authorised: Invega (paliperidone) — Janssen-Cilag International NV
The EMA authorised Invega (paliperidone) from Janssen-Cilag International NV for schizophrenia and related psychotic disorders. This marks i…
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: Efficacy and Safety of tACS vs tDCS in Schizophrenia [NA]
Clinical trial comparing transcranial alternating current stimulation (tACS) versus transcranial direct current stimulation (tDCS) for schiz…
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: Obstructive Sleep Apnea Treatment in Serious Mental Illness [NA]
Clinical trial update for obstructive sleep apnea treatment in individuals with serious mental illness; the study is not currently recruitin…
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: Neurofeedback in Clinical High Risk [NA]
A clinical trial update for a neurofeedback study in individuals at clinical high risk for psychosis, comparing real DMN neurofeedback to sh…
-
FDA approval · 2024-07-08FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Clozapine submitted by Mylan Pharmaceuticals Inc. under the ANDA process.
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related Prediabetes [Phase 2]
A Phase 2 trial evaluating home-based semaglutide for neuroleptic-induced prediabetes in people with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Qualitative Study of Emotional Regulation in Schizophrenia
An update on a qualitative study of emotional regulation in schizophrenia and schizoaffective disorder.
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Cognitive Remediation in Schizophrenia: Efficacy and Role of Neuroplasticity in "Top-down" and "Bottom-up" Mechanisms [NA]
A University of Chile-sponsored clinical trial evaluating cognitive remediation in schizophrenia and the role of neuroplasticity in top-down…